renegade.bio is a purpose-driven, LGBTQ-led, Public Benefit Corporation founded in 2020. They are dedicated to demanding better health and healthcare for all people through their work in the Biotechnology and Health Care industries. The company's slogan emphasizes their commitment to inclusivity and social responsibility. The team, consisting of scientists, entrepreneurs, and community organizers, is focused on providing rapid, cost-effective, end-to-end COVID-19 diagnostic testing for community and public health. Their most recent milestone is the Series A investment received on 01 March 2023, marking a significant step in their journey. The investors participating in this round are yet to be disclosed, but this injection of capital is expected to further fuel renegade.bio's impactful mission.
General Information
BounceWatch is an independent company data service, not affiliated with renegade.bio. To contact renegade.bio, visit renegade.bio.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does renegade.bio compare?
A PDF of renegade.bio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting renegade.bio soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is renegade.bio on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
United States Market
Biotechnology
About renegade.bio
Business keywords: Healthcare Diagnostics, Infectious Diseases, Public Health, COVID-19 Testing, Community Health, Viral Testing, Public Benefit Corporation, High Throughput Diagnostics, Community Organizing, LGBTQ-Led, End-to-End Testing, CLIA Certification, CAP Accreditation
Funding Rounds & Investors (5)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series A | Undisclosed | - |
|
01 Mar 2023 |
| Convertible Note | Undisclosed | - |
|
20 Jan 2023 |
| Convertible Note | Undisclosed | - |
|
03 Sep 2020 |
| Seed | Undisclosed | - |
|
21 Apr 2020 |
| Seed | Undisclosed | - |
|
18 Mar 2020 |
renegade.bio Alternatives & Competitors
View All AlternativesWe turn genetic data into actionable healthcare insights, creating a healthier future for all.
Providing onsite COVID-19 testing solutions for companies, schools, and nursing homes throughout the...
FAQ About renegade.bio
Source: BounceWatch company record for renegade.bio, https://bouncewatch.com/company/renegadebio, updated 3 December 2024. When citing, please name BounceWatch and link this page.